Genetic differences in the cyclophosphamide-induced immune suppression: Weaker suppression of T-cell cytotoxicity by cyclophosphamide activated by CBA mice
- 1 September 1980
- journal article
- research article
- Published by Elsevier in Clinical Immunology and Immunopathology
- Vol. 17 (1) , 38-42
- https://doi.org/10.1016/0090-1229(80)90071-9
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- DIFFERENTIAL CYCLOPHOSPHAMIDE SENSITIVITY OF SUPPRESSOR AND CYTOOXIC CELL PRECURSORSTransplantation, 1978
- Enhancing effect of low dose cyclophosphamide treatment on the in vitro antibody responseEuropean Journal of Immunology, 1977
- Genetic control of specific immune suppression. IV. Responsiveness to the random copolymer L-glutamic acid(50)-L-tyrosine(50) induced in BALB/c mice by cyclophosphamideThe Journal of Experimental Medicine, 1976
- Micromethods for induction and assay of mouse mixed lymphocyte reactions and cytotoxicityEuropean Journal of Immunology, 1975
- Augmentation of delayed-type hypersensitivity by doses of cyclophosphamide which do not affect antibody responses.The Journal of Experimental Medicine, 1975
- Cell‐mediated cytotoxicity to trinitrophenyl‐modified syngeneic lymphocytesEuropean Journal of Immunology, 1974
- A rapid method for the isolation of functional thymus‐derived murine lymphocytesEuropean Journal of Immunology, 1973
- Parity and Optical ActivityNature, 1972
- RAPID IN VITRO DETECTION OF CELLULAR IMMUNITY IN MAN AGAINST FRESHLY EXPLANTED ALLOGENEIC CELLSTransplantation, 1972
- Activation of cyclophosphamide in man and animalsCancer, 1971